Giving primarily to cure muscular dystrophies caused by dysferlin protein deficiency, which includes the clinical presentations Limb-girdle muscular dystrophy type 2B (LGMD2B) and Miyoshi muscular dystrophy 1 (MMD1). The foundation's focused strategy includes funding and actively monitoring the progress of scientific research projects in key pathways towards a cure, providing financial and logistical support to promising drug candidates to accelerate them to clinical trials, funding clinical trials and studies, encouraging collaboration among scientists, and educating LGMD2B/Miyoshi patients about their disease and helping them with their diagnosis (e.g.: funding dysferlin protein and gene mutational analysis).
Sign up to receive alerts for this grantmaker. Alerts will contain information on profile and status
changes; details on newly posted grants; links to new 990 filings; and links to newly posted news
articles, job openings, RFP announcements, and publications.
Please note that alerts will be sent to the e-mail address associated with your account. To change your
e-mail address, please update your user profile.